Recent Quotes (30 days)

You have no recent quotes
chg | %

Nextgen Biomed Ltd  

(Public, TLV:NXGN)   Watch this stock  
Find more results for NXGN
0.00 (0.00%)
Delayed:   5:24PM GMT+3
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range     -
52 week 0.12 - 0.26
Open     -
Vol / Avg. 0.00/35,092.00
Mkt cap 7.25M*
P/E     -
Div/yield     -
EPS -0.07*
Shares 28.99M
Beta     -
Inst. own     -
Oct 18, 2017
Nextgen Biomed Ltd Extraordinary Shareholders Meeting

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -30.06% -42.94%
Return on average equity -34.86% -51.43%
Employees 187 -
CDP Score - -


Azrieli Center, Round Tower 22 Floor
TEL AVIV-YAFO, 6701101
+972-3-6070320 (Phone)
+972-3-6070323 (Fax)

Website links


Nextgen Biomed Ltd., formerly Sela Group.Com Ltd., is an Israel-based company. Previously, the Company provided training and services to the Israeli and global high technology sector, software development, digital hardware design, information security, management of computing systems, information technology (IT), personnel positioning, consultancy, outsourcing, Website casting and Website conferencing in Israel and abroad. The Company's clients included the Israeli Defense Ministry, Raphael, Elisra, Avirnaoutic Industry, Amdocs, BMC, Comverse, Texas Instruments, The National Israeli Electricity Company, General Health Services Company, Bank Leumi, Pelephone, EDS, NDS, ECI Telecom and others. Currently, Nextgen Biomed Ltd. via its subsidiary, Sindolor Medical Ltd., operates research and development of injection devices while reducing pain.

Officers and directors

Asher Zamir Vice President - Finance
Age: 44
Shlomo Zakai Member of the Management Board
Itzhak Israel Director
Age: 37
Eli Arad Independent Director
Age: 40
Eti Cohen Independent Director
Hedan Orenstein Independent Director